Friday, August 02, 2019 8:06:09 AM
The FDA isn't favoring one side, they are saying only one side has presented an accepted scientific study.
You can't combat that with opinion and toxicology reports.
Someone gonna have to step up and take one for the team, and spend some real money getting some solid science...Sorry Self GRAS isn't it, or it would already be moot.
The FDA isn't going to do the research themselves.
The whole industry whines about the FDA who is there in your best interest, to protect you from ingesting things that may be harmful...Like drug ingredients in food.
Until someone shows them undeniable proof...nothing will happen.
Has anyone considered what kind of precedent would be set if they allowed a drug ingredient in food, due to political pressure?
What case would they have for other drug ingredients not finding their way in to food? There are plenty of drugs that can already be proven not to be harmful in the correct dosages.
You can't combat that with opinion and toxicology reports.
Someone gonna have to step up and take one for the team, and spend some real money getting some solid science...Sorry Self GRAS isn't it, or it would already be moot.
The FDA isn't going to do the research themselves.
The whole industry whines about the FDA who is there in your best interest, to protect you from ingesting things that may be harmful...Like drug ingredients in food.
Until someone shows them undeniable proof...nothing will happen.
Has anyone considered what kind of precedent would be set if they allowed a drug ingredient in food, due to political pressure?
What case would they have for other drug ingredients not finding their way in to food? There are plenty of drugs that can already be proven not to be harmful in the correct dosages.
Recent CVSI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:10:09 PM
- CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results • ACCESS Newswire • 05/14/2026 08:00:00 PM
- CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026 • ACCESS Newswire • 05/12/2026 10:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
